A detailed history of Checchi Capital Advisers, LLC transactions in Novartis Ag stock. As of the latest transaction made, Checchi Capital Advisers, LLC holds 18,388 shares of NVS stock, worth $1.99 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
18,388
Previous 18,556 0.91%
Holding current value
$1.99 Million
Previous $1.87 Million 5.07%
% of portfolio
0.1%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$95.27 - $108.47 $16,005 - $18,222
-168 Reduced 0.91%
18,388 $1.78 Million
Q4 2023

Feb 07, 2024

BUY
$92.27 - $101.54 $14,578 - $16,043
158 Added 0.86%
18,556 $1.87 Million
Q3 2023

Nov 09, 2023

BUY
$94.73 - $105.13 $39,123 - $43,418
413 Added 2.3%
18,398 $1.87 Million
Q2 2023

Aug 09, 2023

BUY
$92.52 - $104.91 $63,191 - $71,653
683 Added 3.95%
17,985 $1.81 Million
Q1 2023

May 05, 2023

SELL
$80.03 - $92.81 $19,927 - $23,109
-249 Reduced 1.42%
17,302 $1.59 Million
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $10,274 - $12,582
-136 Reduced 0.77%
17,551 $1.59 Million
Q3 2022

Nov 09, 2022

BUY
$74.61 - $87.26 $820 - $959
11 Added 0.06%
17,687 $1.34 Million
Q2 2022

Aug 11, 2022

BUY
$80.52 - $93.75 $153,793 - $179,062
1,910 Added 12.11%
17,676 $1.52 Million
Q1 2022

May 09, 2022

BUY
$80.11 - $90.62 $10,574 - $11,961
132 Added 0.84%
15,766 $1.38 Million
Q4 2021

Feb 09, 2022

SELL
$79.7 - $88.13 $6,296 - $6,962
-79 Reduced 0.5%
15,634 $1.37 Million
Q3 2021

Nov 09, 2021

BUY
$81.78 - $95.14 $15,211 - $17,696
186 Added 1.2%
15,713 $1.29 Million
Q2 2021

Aug 06, 2021

SELL
$85.24 - $94.15 $96,491 - $106,577
-1,132 Reduced 6.8%
15,527 $1.42 Million
Q1 2021

May 10, 2021

BUY
$83.5 - $98.47 $6,930 - $8,173
83 Added 0.5%
16,659 $1.42 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $60,582 - $73,277
-776 Reduced 4.47%
16,576 $1.57 Million
Q3 2020

Nov 10, 2020

BUY
$82.14 - $91.0 $77,211 - $85,540
940 Added 5.73%
17,352 $1.51 Million
Q2 2020

Aug 12, 2020

BUY
$80.93 - $91.1 $27,192 - $30,609
336 Added 2.09%
16,412 $1.43 Million
Q1 2020

May 07, 2020

BUY
$70.67 - $99.01 $96,181 - $134,752
1,361 Added 9.25%
16,076 $1.33 Million
Q4 2019

Feb 07, 2020

SELL
$84.35 - $95.37 $170,218 - $192,456
-2,018 Reduced 12.06%
14,715 $1.39 Million
Q3 2019

Nov 06, 2019

SELL
$85.54 - $94.26 $30,794 - $33,933
-360 Reduced 2.11%
16,733 $1.45 Million
Q2 2019

Aug 06, 2019

SELL
$75.4 - $92.8 $26,390 - $32,480
-350 Reduced 2.01%
17,093 $1.56 Million
Q1 2019

May 09, 2019

BUY
$75.32 - $86.15 $117,875 - $134,824
1,565 Added 9.86%
17,443 $1.68 Million
Q4 2018

Feb 07, 2019

SELL
$73.66 - $82.02 $187,170 - $208,412
-2,541 Reduced 13.8%
15,878 $1.36 Million
Q3 2018

Oct 29, 2018

SELL
$66.94 - $77.43 $110,852 - $128,224
-1,656 Reduced 8.25%
18,419 $1.59 Million
Q2 2018

Aug 06, 2018

BUY
$64.91 - $73.36 $232,767 - $263,068
3,586 Added 21.75%
20,075 $1.52 Million
Q1 2018

May 01, 2018

BUY
$70.39 - $84.15 $24,495 - $29,284
348 Added 2.16%
16,489 $1.33 Million
Q4 2017

Feb 02, 2018

BUY
$72.33 - $77.64 $5,063 - $5,434
70 Added 0.44%
16,141 $1.36 Million
Q3 2017

Nov 02, 2017

BUY
$74.14 - $77.27 $1.19 Million - $1.24 Million
16,071
16,071 $1.38 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.